Back to Screener

XMAX, Inc. - Common Stock (XMAX)

NASDAQ Small Cap
$8.60
Market Cap: $547M
Data as of Mar 31, 2026 (TTM)

Investment Snapshot

  • P/B of 13.56 — trading above book value
  • Piotroski F-Score 3/9 — signs of financial weakness
  • Loss-making — negative ROE of -3.9%
  • Revenue growing at 73% annually

XMAX, Inc. - Common Stock (XMAX) is a publicly traded company, listed on the NASDAQ , with a market capitalisation of $547 million . Key value metrics: P/B ratio 13.56, Piotroski F-Score 3 out of 9 .

Value Score

Key Metrics

P/E Ratio
13.56
EPS
$-0.02
Div. Yield
PEG Ratio
P/S Ratio
EV/EBITDA
ROE
ROA
Gross Margin
Op. Margin
Net Margin
Debt/Equity
Current Ratio
Data sourced from SEC EDGAR and Polygon.io. Methodology.

XMAX, Inc. - Common Stock — Fundamental Analysis Summary

On financial health, XMAX shows a weak Piotroski F-Score of 3/9, a signal of deteriorating financial health, and negative return on equity of -3.9%.

StockPik's composite Value Score for XMAX is 22/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.

XMAX reports a moderate gross margin of 26.0% and a negative operating margin of -8.5%.

XMAX shows revenue growing at 73% year-over-year, with earnings growing at 39%.

How is the Value Score calculated?
Read our full methodology →
What is the Piotroski F-Score?
The 9-point financial health score explained, with worked examples →
Previous
XLO
Next
XMTR